drugset / Trial / NCT02094599

A Study of the Abuse Potential of Dronabinol in Recreational Cannabinoid Users

NCT02094599

Phase 1 Completed 43 enrolled INSYS Therapeutics Inc
NaSingle-groupTriple-blind

Summary

The primary objective of this study is to evaluate the abuse potential of dronabinol oral solution in recreational cannabinoid users.

Timeline

Start
2014-02
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Dronabinol Other / unclassified 10 mg Oral
Subject Dronabinol Other / unclassified 30 mg Oral

Indications